News

A new drug reduced the risk of relapse and increased survival by five months, according to a recent study. The results were presented at a cancer...

In the past 20 years, we’ve been very fortunate in the development of effective myeloma therapies and have seen remarkable progress for our...

For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk...

Guyon Espiner reveals how lung cancer patients are buying cut-price drugs from India, as other New Zealanders fundraise, petition and apply for...

Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder and is described as an intermediate stage between monoclonal...

Lenalidomide (Revlimid) significantly reduced the risk for smoldering multiple myeloma to progress to cancer among patients with moderate to high...

“More protest action is on the cards if this government isn’t prepared to give Pharmac more money “, said mother of three Joy Wilkie of Ngati...

Multiple myeloma is a disease characterized by the proliferation of plasma cells which can lead to the abnormally high production of monoclonal...

Minimal residual disease status appeared prognostic for PFS at three specific time points for patients with multiple myeloma, according to results...

An investigational BCMA-directed chimeric antigen receptor (CAR) T-cell (CAR-T) therapy, bb2121, appeared safe and effective for previously treated...

Patient advocacy group Myeloma New Zealand has joined forces with other patient groups to petition Parliament to approve funding for...